WebFounders Cedric Francois, Pascal Deschatelets Operating Status Active Last Funding Type Post-IPO Equity Legal Name Apellis Pharmaceuticals, Inc. Stock Symbol NASDAQ:APLS Company Type For Profit Contact Email [email protected] Phone Number 502-241-4114 WebJoining Apellis Pharmaceuticals - Employee Onboarding. The prevailing opinion from Comparably users in Lexington, KY about their company is that it was very prepared on their first day. ... Dr. Pascal Deschatelets, PhD. Co-founded Apellis Pharmaceuticals, Inc. in November 2009 and has been its Chief Operating... Ahmad Sadr VP - Technical ...
APLS Apellis Pharmaceuticals Inc. Stock Overview (U.S.: …
WebApr 12, 2024 · Apellis Pharmaceuticals, Inc. ( NASDAQ:APLS – Get Rating) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 10th. The shares... WebFeb 22, 2024 · Deschatelets Pascal Apellis Pharmaceuticals, Inc. [ APLS ] Director 10% Owner X Officer (give title below) Other (specify below) Chief Scientific Officer C/O … ladybridge club house cheadle hulme
investors.apellis.com
WebOur Products - Apellis Our Products Please see full Prescribing Information, including Boxed WARNING and Medication Guide. Patients and healthcare providers in the United States can learn more at: EMPAVELI.COM … WebPascal DESCHATELETS, Chief Scientific Officer Cited by 1,262 of Apellis Pharmaceuticals, Westwood Read 33 publications Contact Pascal DESCHATELETS WebAt Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. We Advance Courageous Science Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. property management lima ohio